Seven new innovative drugs on reimbursement list in Hungary
2010-03-08
Seven new innovative drugs were included in a February amendment to the drug reimbursement list in Hungary. This is considered a significant improvement, because in 2009 no innovative drugs were included in the reimbursement scheme due to budget restrictions. There are also twenty new products placed on a waiting list for admission.
Meanwhile, in December 2009 the Hungarian Health Ministry modified the regulations pertaining to the rules of access to conditionally reimbursed drugs. The new amendment stipulates that up to 50 patients per year can be granted the conditional reimbursement of one therapy. The Hungarian Association of Innovative Pharmaceutical Manufacturers has criticised the modification, which could, in their opinion, limit the equal access of patients to effective treatment. According to Magyar Nemzet, the Hungarian Cancer Society has challenged the amendment before the Constitutional Court. The Ministry has refused to withdraw it, claiming that it serves the interests of patients and prompts drug manufacturers to adjust their prices in order to receive reimbursement, as this is the only way to provide continuous and safe access to medicinal products.
internet service providing market news and sector articles
Central Europe Pharma Online provides news, articles and market data on the pharmaceutical market in Bulgaria, Czech Republic, Hungary, Romania, Poland and Slovakia, from manufacturers and distributors to medical devices and research developments. Over 120 industry updates, covering manufacturers and distributors, medical news and research developments, together with news on laws and regulations governing the pharmaceutical sector are added on a regular basis. For timely news delivery, custom newsletters can be sent directly to your e-mail account, with content personalisation.
Subscription 1 year
Language: English
Delivery: online access
Central Europe Pharma News is a bi-weekly newsletter delivered in PDF format directly to your inbox. Each edition of the newsletter delivers news and analysis of the pharmaceutical sector in Bulgaria, Czech Republic, Hungary, Romania, Poland and Slovakia, including an in-depth feature on the pharmaceutical industry in the Central & Eastern Europe region written by PMR market analysts. A list of upcoming events relevant to the region and a company index are included in every issue.
Date: Periodic publication
Language: English
Delivery: PDF file
PMRis a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.
PMR Online Access
Browse and search in our archive »
Subscribe to PMR RSS NEWS channels » 
